Skip to main content

Alterity Therapeutics Limited - American Depositary Shares (NQ:ATHE)

4.560 -0.220 (-4.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 22,763
Open 4.630
Bid (Size) 4.540 (100)
Ask (Size) 4.900 (100)
Prev. Close 4.780
Today's Range 4.540 - 4.876
52wk Range 2.660 - 5.892
Shares Outstanding 2,084,016,678
Dividend Yield N/A

Performance

YTD
+44.3%
+44.3%
1 Month
-0.1%
-0.1%
3 Month
+11.8%
+11.8%
6 Month
+29.1%
+29.1%
1 Year
-8.8%
-8.8%

More News

Read More

Frequently Asked Questions

Is Alterity Therapeutics Limited - American Depositary Shares publicly traded?
Yes, Alterity Therapeutics Limited - American Depositary Shares is publicly traded.
What exchange does Alterity Therapeutics Limited - American Depositary Shares trade on?
Alterity Therapeutics Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alterity Therapeutics Limited - American Depositary Shares?
The ticker symbol for Alterity Therapeutics Limited - American Depositary Shares is ATHE on the Nasdaq Stock Market
What is the current price of Alterity Therapeutics Limited - American Depositary Shares?
The current price of Alterity Therapeutics Limited - American Depositary Shares is 4.560
When was Alterity Therapeutics Limited - American Depositary Shares last traded?
The last trade of Alterity Therapeutics Limited - American Depositary Shares was at 08/27/26 04:00 PM ET
What is the market capitalization of Alterity Therapeutics Limited - American Depositary Shares?
The market capitalization of Alterity Therapeutics Limited - American Depositary Shares is 9.50B
How many shares of Alterity Therapeutics Limited - American Depositary Shares are outstanding?
Alterity Therapeutics Limited - American Depositary Shares has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.